# Seres Therapeutics, Inc.: Form 8-K, filed May 7, 2024

- Company: [Seres Therapeutics, Inc.](/companies/mcrb.md) (CIK 1609809)
- Form: 8-K
- Filed: 2024-05-07
- Accepted by EDGAR: May 7, 2024, 17:18 ET
- Period: 2024-05-01
- Accession: 0001193125-24-133298
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1609809/000119312524133298/d833710d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1609809/000119312524133298/

## Items reported

- Item 2.04: Item not in the standard list

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1609809/000119312524133298/d833710d8k.htm

Filed May 7, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-133298. Last ingested by Listed: Nov 4, 2026, 10:08 ET. No prices; not investment advice.
